Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales
Herbalife NYSE: HLF reported second-quarter net sales of $1.3 billion, up 5.4% from a year earlier and at the high end of its guidance range, as the nutrition company recorded its fourth consecutive q